Misc. news stories
The psychedelic experience can be rough on a person’s ego. Those who experiment with magic mushrooms and LSD often describe a dissolution of the self, otherwise known as ego-death, ego-loss, or ego-disintegration.
A baby has become the first to get a cannabis-derived medicine in a trial to help those born with a condition that can lead to brain damage.
As magic mushrooms make the shift from recreational drug to mental health treatment, patients won’t be eating caps and stems, but a synthetic product made in a lab—one that can be patented and profited from.
An international study involving Monash physicists has cornered a new approach to measure consciousness, potentially changing our understanding of complex neurological problems.
The results of the interim analysis “are the most powerful evidence yet that MDMA-assisted psychotherapy could help transform the lives of people suffering from PTSD.”
In August of 1951, a strange illness descended on the small French town of Pont-Saint-Esprit. Victims complained of abdominal pains, delirium and hallucinations of flames and hellish creatures.
While much of the new research on psychedelics show its potentially high efficacy for treating psychological disorders, relatively little research has been done to demonstrate their uses for the treatment of chronic pain conditions.
One ecstasy trial reached a milestone when it was approved to treat people with post-traumatic stress disorder in America. This could be good timing for the UK too.
The COVID-19 pandemic has resulted in the widespread disruption of our usual routines. The ambiguity of when it will end, how things will unfold and what will happen in the future has resulted in a collective liminal state, a kind of a waiting area on the threshold of change.
Encounters with inter-dimensional beings, atheists discovering belief, and the bizarre world of DMT-induced entities. A trip to the fringes of psychedelic science.
A British cannabis producer has been acquired by a US-based private equity fund in a multimillion-pound deal which some say could accelerate the legalisation of the recreational drug in the UK.
Imagine a psychedelic that promises you’ll never have a bad trip and resets your brain in such a way that you wouldn’t have to depend on antidepressants.
Once stigmatized across the western world, the likes of MDMA, LSD and magic mushrooms are taking back their place in the world of medicine.
Two drug policy reform campaigns in Oregon are teaming up as they both work to collect enough signatures to qualify for the state’s November ballot.
Image from Psilocybe cubensis (Wiki Commons)
The magic mushroom, a miraculous drug in human history. Once used by religious leaders in ancient societies, they have now been downgraded to the same level as other recreational drugs.